File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.3390/vaccines9070792
- Scopus: eid_2-s2.0-85111387888
- PMID: 34358208
- WOS: WOS:000677146100001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Acceptance of COVID-19 Vaccination in Cancer Patients in Hong Kong: Approaches to Improve the Vaccination Rate
Title | Acceptance of COVID-19 Vaccination in Cancer Patients in Hong Kong: Approaches to Improve the Vaccination Rate |
---|---|
Authors | |
Keywords | cancer vaccination acceptance anxiety COVID-19 |
Issue Date | 2021 |
Publisher | MDPI AG. The Journal's web site is located at http://www.mdpi.com/journal/vaccines/ |
Citation | Vaccines , 2021, v. 9 n. 7, p. article no. 792 How to Cite? |
Abstract | Emerging efficacy and safety data have led to the authorization of COVID-19 vaccines worldwide, but most trials excluded patients with active malignancies. This study evaluates the intended acceptance of COVID-19 vaccination in cancer patients in Hong Kong. Methods: 660 adult cancer patients received a survey, in paper or electronic format, between 31 January 2021 and 15 February 2021. The survey included patient’s clinical characteristics, perceptions of COVID-19 and vaccination, vaccine knowledge, cancer health literacy, and Hospital Anxiety and Depression scale (HADS). The primary outcome was the intended acceptance of COVID-19 vaccine in cancer patients. Multivariable analysis was performed to identify factors associated with intended acceptance. Results: The intended acceptance of COVID-19 vaccination was 17.9%. A total of 487 (73.8%) believed that vaccination could prevent them from infection. Over 70% worried about vaccine negative effects on cancer and its side effects. Factors associated with intended acceptance included higher level of “belief in vaccine on preventing them from getting COVID-19”, less worry about long-term side effects of vaccine, lower level of cancer health literacy, and normal HADS (Depression scale). Conclusions: To improve vaccine acceptance rate, public education campaigns specific to cancer patients to gain their trust in efficacy and relieve their worries are needed. |
Persistent Identifier | http://hdl.handle.net/10722/302053 |
ISSN | 2023 Impact Factor: 5.2 2023 SCImago Journal Rankings: 1.201 |
PubMed Central ID | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chan, WL | - |
dc.contributor.author | Ho, YH | - |
dc.contributor.author | Wong, CKH | - |
dc.contributor.author | Choi, HCW | - |
dc.contributor.author | Lam, KO | - |
dc.contributor.author | Yuen, KK | - |
dc.contributor.author | Kwong, D | - |
dc.contributor.author | Hung, I | - |
dc.date.accessioned | 2021-08-21T03:30:54Z | - |
dc.date.available | 2021-08-21T03:30:54Z | - |
dc.date.issued | 2021 | - |
dc.identifier.citation | Vaccines , 2021, v. 9 n. 7, p. article no. 792 | - |
dc.identifier.issn | 2076-393X | - |
dc.identifier.uri | http://hdl.handle.net/10722/302053 | - |
dc.description.abstract | Emerging efficacy and safety data have led to the authorization of COVID-19 vaccines worldwide, but most trials excluded patients with active malignancies. This study evaluates the intended acceptance of COVID-19 vaccination in cancer patients in Hong Kong. Methods: 660 adult cancer patients received a survey, in paper or electronic format, between 31 January 2021 and 15 February 2021. The survey included patient’s clinical characteristics, perceptions of COVID-19 and vaccination, vaccine knowledge, cancer health literacy, and Hospital Anxiety and Depression scale (HADS). The primary outcome was the intended acceptance of COVID-19 vaccine in cancer patients. Multivariable analysis was performed to identify factors associated with intended acceptance. Results: The intended acceptance of COVID-19 vaccination was 17.9%. A total of 487 (73.8%) believed that vaccination could prevent them from infection. Over 70% worried about vaccine negative effects on cancer and its side effects. Factors associated with intended acceptance included higher level of “belief in vaccine on preventing them from getting COVID-19”, less worry about long-term side effects of vaccine, lower level of cancer health literacy, and normal HADS (Depression scale). Conclusions: To improve vaccine acceptance rate, public education campaigns specific to cancer patients to gain their trust in efficacy and relieve their worries are needed. | - |
dc.language | eng | - |
dc.publisher | MDPI AG. The Journal's web site is located at http://www.mdpi.com/journal/vaccines/ | - |
dc.relation.ispartof | Vaccines | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | cancer | - |
dc.subject | vaccination | - |
dc.subject | acceptance | - |
dc.subject | anxiety | - |
dc.subject | COVID-19 | - |
dc.title | Acceptance of COVID-19 Vaccination in Cancer Patients in Hong Kong: Approaches to Improve the Vaccination Rate | - |
dc.type | Article | - |
dc.identifier.email | Chan, WL: winglok@hku.hk | - |
dc.identifier.email | Choi, HCW: hcchoi@hku.hk | - |
dc.identifier.email | Lam, KO: lamkaon@hku.hk | - |
dc.identifier.email | Kwong, D: dlwkwong@hku.hk | - |
dc.identifier.authority | Chan, WL=rp02541 | - |
dc.identifier.authority | Choi, HCW=rp02815 | - |
dc.identifier.authority | Lam, KO=rp01501 | - |
dc.identifier.authority | Kwong, D=rp00414 | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.3390/vaccines9070792 | - |
dc.identifier.pmid | 34358208 | - |
dc.identifier.pmcid | PMC8310340 | - |
dc.identifier.scopus | eid_2-s2.0-85111387888 | - |
dc.identifier.hkuros | 324283 | - |
dc.identifier.volume | 9 | - |
dc.identifier.issue | 7 | - |
dc.identifier.spage | article no. 792 | - |
dc.identifier.epage | article no. 792 | - |
dc.identifier.isi | WOS:000677146100001 | - |
dc.publisher.place | Switzerland | - |